Board Approves Share Repurchase Authorisation Of US$20mn

News: American Oriental Bioengineering, a rapidly-growing Chinese company, has announced that its board of directors has approved a share repurchase authorisation of up to US$20mn of the company's outstanding common stock over the next two years. Purchases under this programme will be financed from available working capital. According to the company, the programme will boost shareholder value over time.

To read the full article, please choose one of the following options: